- active not recruitingPHASE3
Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential Approach to Treat Myasthenia Gravis
This study is testing a new treatment, called Descartes-08, for myasthenia gravis. It uses your own cells, changed to fight the disease. We want to see if it's safe and helps people with a specific type of this condition.
United States · Canada · Italy - recruitingPHASE3
Efgartigimod in IVIG Dependent Myasthenia Gravis Patients
This study looks at a new drug, efgartigimod, as a potential replacement for IVIG treatment in people with myasthenia gravis. Researchers want to see if it works as well as IVIG and is safe. Patients will receive efgartigimod infusions over 26 weeks.
Canada - enrolling by invitationNA
The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.
This study looks at how walking aids and training can help people with certain muscle and nerve conditions fall less often. It aims to improve their safety and daily life by finding the best ways to use these aids.
Germany